As of Feb 28, 2025
Putnam ETF Trust Putnam BioRevolution ETF (ARCA: SYNB)
Ticker | Name | Share % | |
---|---|---|---|
TMO | Thermo Fisher Scientific Inc | 8.45% | |
DHR | Danaher Corp | 7.28% | |
NVDA | NVIDIA Corporation | 3.89% | |
GOOG | Alphabet | 6.23% | |
BIO | Bio Rad Laboratories A | 5.05% | |
CTVA | Corteva Inc | 5.13% | |
CO | Novonesis (Novozymes)-Adr | 5.13% | |
ABBV | Abbvie Inc | 5.83% | |
ASND | Ascendis Pharma A/S | 3.80% | |
LLY | Eli Lilly & Co | 4.49% | |
AZN | Astrazeneca Plc-Spons Adr | 4.50% | |
GOOGL | Alphabet Inc-cl A | 4.06% |
The SYNB ETF is currently trading at $25.56, which represents a -5.61% change. Over the past 52 weeks, the ETF has traded as high as $33.23 and as low as $27.08.
The expense ratio of SYNB is 0.71%. This represents the annual fee that all funds or ETFs charge their shareholders.
The total Assets Under Management (AUM) for SYNB is 4.89M. This represents the total market value of the assets managed by the ETF.
SYNB follows a Large Cap Blend investment style.
The top holdings of SYNB include: TMO (8.45%), DHR (7.28%), NVDA (3.89%), GOOG (6.23%), BIO (5.05%). These represent the largest positions in the ETF's portfolio.
Average daily volume data for SYNB is currently not available.